Pharmacy

The FDA granted accelerated approval to Ultragenyx Pharmaceutical’s Genglycos, the first approved treatment for glycogen storage disease type Ia. The one-time AAV8-based gene therapy is approved to reduce daily cornstarch intake as an adjunct to nutritional management in adults and…

The Pharmaceutical Care Management Association and its members committed to sharing TrumpRx’s cash prices for drugs through their real-time benefit tools and other cost transparency platforms. An Aug. 13 news release said the association coordinated with the Trump administration and CMS Administrator…

Hospitals and health systems are pouring capital into pharmacy operations this summer, from rural cardiology partnerships to $30 million automated fulfillment centers, as they look to capture more prescription volume, cut readmissions and compete with retail pharmacy closures. Here’s a…

When combined with immunotherapy, an mRNA-based vaccine has been found to cut the risk of melanoma recurrence and distant metastasis more than immunotherapy alone. Results from the phase 3 trial of the vaccine, called intismeran, will be presented at an…

Pittsburgh-based Allegheny Health Network has saved $4.2 million and significantly reduced medication stockouts after shifting from managing pharmacy inventory at individual hospitals to an enterprisewide strategy, according to Laura Mark, PharmD, vice president of pharmacy. Speaking on Becker’s “Pharmacy Leadership…

Big pharma’s last two weeks have included a phase 3 setback, a new FDA approval and a fresh round of 340B litigation. Here’s what to know: 

Hospitals and health systems have made several pharmacy leadership changes in recent weeks. Here are seven recent moves:

UC San Diego Health’s specialty pharmacy program has earned Rare Disease Certification from the Utilization Review Accreditation Commission, becoming the first health system in the San Diego region to earn the designation. The program is one of only three certified…

The American Hospital Association is again pressing CMS to require drugmakers to provide negotiated Medicare drug prices upfront rather than through retrospective rebates. The group filed comments Aug. 17 on a CMS proposed rule that would codify requirements for the…

AstraZeneca has ended a phase 3 clinical trial of the drug volrustomig for the treatment of metastatic non-small cell lung cancer. The trial was specifically evaluating the drug in combination with chemotherapy compared to pembrolizumab and chemotherapy in metastatic non-small…